Viewing Study NCT05745857


Ignite Creation Date: 2025-12-24 @ 6:35 PM
Ignite Modification Date: 2026-06-06 @ 11:02 PM
Study NCT ID: NCT05745857
Status: UNKNOWN
Last Update Posted: 2023-02-27
First Post: 2023-02-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas
Sponsor: University Medical Center Groningen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Barrett's Esophagus Without Dysplasia View
None Barrett Oesophagitis With Dysplasia View
None Esophageal Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Fluorescence molecular endoscopy View
None Spectroscopy View
None Barrett's esophagus View
None Esophageal adenocarcinoma View